Iron Oxide Hyperthermia And Radiation Cancer Treatment.
Autor: | Cassim S; Thayer School of Engineering, Dartmouth College, Hanover, NH 03755 USA., Giustini A; Dartmouth-Hitchcock Medical Center, Dartmouth Medical School, Lebanon, NH 03766 USA ; Thayer School of Engineering, Dartmouth College, Hanover, NH 03755 USA., Petryk A; Thayer School of Engineering, Dartmouth College, Hanover, NH 03755 USA., Strawbridge R; Dartmouth-Hitchcock Medical Center, Dartmouth Medical School, Lebanon, NH 03766 USA., Hoopes P; Dartmouth-Hitchcock Medical Center, Dartmouth Medical School, Lebanon, NH 03766 USA ; Thayer School of Engineering, Dartmouth College, Hanover, NH 03755 USA. |
---|---|
Jazyk: | angličtina |
Zdroj: | Proceedings of SPIE--the International Society for Optical Engineering [Proc SPIE Int Soc Opt Eng] 2009 Feb 23; Vol. 7181, pp. 71810O. |
DOI: | 10.1117/12.810035 |
Abstrakt: | It is established that heat can enhance the effect of radiation cancer treatment. Due to the ability to localize thermal energy using nanoparticle hyperthermia, as opposed to other, less targeted, hyperthermia modalities, it appears such enhancement could be accomplished without complications normally associated with systemic or regional hyperthermia. This study employs non-curative (suboptimal), doses of heat and radiation, in an effort to determine the therapeutic enhancement potential for IONP hyperthermia and radiation. Methods: MTG-B murine breast adenocarcinoma cell are inoculated into the right flanks of female CH3/HEJ mice and grown to volumes of 150mm 3 + / Results: Preliminary results suggest the addition of a modest IONP hyperthermia to 15 Gy radiation achieved an approximate 50% increase in tumor regrowth delay as compared to a 15 Gy radiation treatment alone. The therapeutic effects of IONP heat and radiation combined were considered additive, however in mice that demonstrated complete response (no tumor present after 30 days), the effect was considered superadditive or synergistic. Although this data is very encouraging from a multimodality cancer therapy standpoint, additional temporal and dose related information is clearly necessary to optimize the therapy. |
Databáze: | MEDLINE |
Externí odkaz: |